Vibrio cholerae O1 Variant with Reduced Susceptibility to Ciprofloxacin, Western Africa

by Marie-Laure Quilici, Denis Massenet, Bouba Gake, Barem Bwalki, David M. Olson
Published 2010-11-01

Survival and growth of Vibrio cholerae and Escherichia coli in treated groundwater consumed in northern Cameroon

by Moussa Djaouda, Zoua Wadoubé, Odile Baponwa, Soumayyata Youssoufa, Bouba Gaké, Song Liang, Moïse Nola
Published 2020-11-01

Low seroprevalence of Zika virus in Cameroonian blood donors

by Bouba Gake, Marie A. Vernet, Isabelle Leparc-Goffart, Jan Felix Drexler, Ernest A. Gould, Pierre Gallian, Xavier de Lamballerie
Published 2017-07-01

Correction to: Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

by Elif Nurtop, Paola Mariela Saba Villarroel, Boris Pastorino, Laetitia Ninove, Jan Felix Drexler, Yelin Roca, Bouba Gake, Audrey Dubot-Peres, Gilda Grard, Christophe Peyrefitte, Stéphane Priet, Xavier de Lamballerie, Pierre Gallian
Published 2019-01-01

Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

by Elif Nurtop, Paola Mariela Saba Villarroel, Boris Pastorino, Laetitia Ninove, Jan Felix Drexler, Yelin Roca, Bouba Gake, Audrey Dubot-Peres, Gilda Grard, Christophe Peyrefitte, Stéphane Priet, Xavier de Lamballerie, Pierre Gallian
Published 2018-12-01

Impact of MenAfriVac on Meningococcal A Meningitis in Cameroon: A Retrospective Study Using Case-by-Case-Based Surveillance Data from 2009 to 2015

by Bouba Gake, Bonaventure Babinne Graobe, Bouba Abdouraman, Crescence Satou Ngah, Ahmadou Aissatou, Nelly-Michèle Gake, Elise Claudine Seukap, Elias Nchiwan Nukenine, Alain G. Etoundi Mballa, Marie-Christine Fonkoua, Jean-Pierre Lombart
Published 2021-01-01